VAERS reports by lot

GSK DTaP/Tdap lot K4979: VAERS reports

22 VAERS reports list lot K4979 as a GSK DTaP/Tdap vaccine, received between 2025-10-13 and 2026-03-17. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
0%
Marked serious
0
With a death outcome
6
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1729%
Neurological1322%
Musculoskeletal712%
General / Systemic (non-local)712%
Cardiac / Cardiovascular610%
Dermatological (non-injection-site)59%
Allergic / Anaphylactic12%
Respiratory12%
Gastrointestinal12%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Minnesota3
Texas3
South Carolina2
New Jersey1
California1
Maryland1
Nevada1
Hawaii1
Arizona1
Oregon1
Florida1
Tennessee1

Reports by month received

MonthReportsBar
2025-106
2025-119
2025-121
2026-011
2026-023
2026-032

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): HF2YA · J947T · JF7DM · K5F5R · L5229 · LP2G2

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.